Literature DB >> 15370797

Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?

Maria Schaufelberger1, Claes-Håkan Bergh, Kenneth Caidahl, Robert Eggertsen, Eva Furenäs, Göran Lindstedt, Thomas Nilsson, Kari Stefferud, Karl Swedberg.   

Abstract

OBJECTIVE: To investigate plasma brain natriuretic peptide (p-BNP) in consecutive primary care patients for heart failure screening.
DESIGN: Open, descriptive.
SETTING: Three primary care clinics, university hospital.
SUBJECTS: 291 consecutive patients, > or =40 years. MAIN OUTCOME MEASURES: p-BNP and general practitioners estimated probability of CHF.
RESULTS: Median p-BNP was 29 ng/L. In 42% p-BNP was >40 ng/L in the first sample. In 41 patients further investigated, median p-BNP was 98 ng/L, with a correlation between p-BNP and physicians' estimation of probability of heart failure (r=0.469, p<0.0001). New York Heart Association class was correlated to p-BNP (r=0.343, p=0.034). No correlation between ejection fraction and p-BNP was seen.
CONCLUSION: P-BNP concentrations in unselected primary care patients of 40 years of age or above were elevated in a larger proportion of patients than previously reported. Owing to the low specificity, p-BNP concentration limits have to be defined before the test can be used for screening in primary care.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370797     DOI: 10.1080/02813430410006594

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  1 in total

1.  Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.

Authors:  Mona Olofsson; Kurt Boman
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.